- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 08:25 | Strong Q2, driven by multiple growth levers: ZEAL delivered a strong Q2, driven by robust core lottery ... | 305 | ZEAL delivered a strong Q2, ahead of our estimates on both sales and EBITDA, with EBITDA up 33% yoy despite ongoing investments into the proprietary lottery formats.ZEAL grew more than twice as fast... ► Artikel lesen | ||
| 08:25 | Quality over count, chg.: NAGA's first profitable half confirms a step-change in earnings quality, ... | 288 | NAGA's preliminary H1 results mark the first profitable half in the group's history. Sales came in at € 27.7m (-14% yoy), while EBITDA rose 47% yoy (fx-adj. +64% yoy) to € 4.4m and net profit turned... ► Artikel lesen | ||
| Mi | DEMIRE AG: Earnings Call für Investoren am 13.08.2026: NuWays veranstaltet am 13.08.2026 um 11:00 Uhr ... | 403 | Die NuWays AG veranstaltet einen Earnings Call mit DEMIRE AG. Unternehmen: DEMIRE AGDatum: 13.08.2026 11:00 Uhr Speaker: Tim Brückner, und Dirk Rüffel, Dr. Nach einer Präsentation besteht die Möglichkeit... ► Artikel lesen | ||
| Mi | Flughafen Wien: Q2 preview: guidance leaves ample room for upside, chg.: Cost savings should offset the tariff cut in ... | 338 | Flughafen Wien will release its H1 report on 19 August. We expect resilient Q2 figures and see the conservative FY26 guidance paving the way for positive surprises in H2. Here is what to expect:Q2 sales... ► Artikel lesen | ||
| Di | Entering the healthcare vertical; Chg.: QBY acquires 51% in GITG, an SAP healthcare specialist with ... | 6.529 | Yesterday, QBY announced the acquisition of a 51% stake in Hamburg-based GITG, a c. 40 employee SAP healthcare specialist. The key takeaways: GITG has implemented and supported SAP in healthcare since... ► Artikel lesen | ||
| Fr | Bittium: Q2 preview: backlog supports growth, H2 has catalyst firepower: H1 preview; Q2'26e net sales +19% yoy ... | 500 | Bittium will publish its H1'26 report on August 7. Publicly announced orders during Q2'26 totalled € 26.6m, the vast majority from FDF and set for delivery during FY26. Growth this year is still supported... ► Artikel lesen | ||
| Fr | Phase 3 from a position of strength: Fresh funding allows Pentixapharm to enter Phase 3 from a position ... | 454 | Pentixapharm sits at the intersection of a high-prevalence indication and one of the fastest-growing fields of medicine: radiopharma. Following the recent capital increase, the company is now well positioned... ► Artikel lesen | ||
| 30.07. | Bidder validation, delayed conversion; chg.: A withdrawn takeover approach from Red Cat confirms the ... | 387 | Withdrawn Red Cat approach underlines USV as a core growth market. Steyr Motors had attracted a preliminary, non-binding takeover approach from US drone and robotics group Red Cat Holdings. Red Cat... ► Artikel lesen | ||
| 30.07. | Nabaltec Q2 preview: Passed the trough, returning to growth: H1 report due Aug 20 offers first proof point for ... | 421 | Nabaltec will publish its H1 figures on August 20. Following a soft Q1 (sales -2.7% yoy), management guided for a gradual return to revenue growth starting from Q2, driven by a broad-based demand pick-up.... ► Artikel lesen | ||
| 30.07. | Material momentum triggers sig. guidance hike; PT Up: INDUS hikes FY26 guidance to €1.9-2.1bn sales ... | 488 | Yesterday, INDUS significantly hiked its guidance in expectation of an exceptional Q2 result, given strong momentum in Material Solutions related to the tungsten special situation. In detail:Prel. Q2... ► Artikel lesen | ||
| 29.07. | Q2 set to confirm earnings acceleration: GFT's Q2 should confirm an EBIT growth acceleration. While ... | 679 | GFT reports H1 results on 6 August, and we expect a second consecutive quarter of adj. EBIT growing well ahead of sales. The recent IBM and Accenture news do not read across to GFT, in our view, while... ► Artikel lesen | ||
| 29.07. | Q3e: Continued restructuring expected: Hoenle's Q3 FY25/26 results due 18 August. Flat-ish topline ... | 385 | hoenle looks set to publish its Q3 FY25/26 results August 18th. Here is what to expect: A flat-ish topline from mixed segment performance coming in at € 22.6m (eNuW: -0.1% yoy). We expect the segments... ► Artikel lesen | ||
| 28.07. | INDUS Holding: Material momentum: double-digit Q2 ahead: Ahead of Aug. 12 H1 release, we expect Q2 sales of € 486m ... | 581 | INDUS is scheduled to release its H1 report on August 12th. We expect strong growth on top- and bottom-line for Q2. In detail: Double-digit Q2 sales growth (eNuW: +12% yoy), leading to € 486m (eNuW)... ► Artikel lesen | ||
| 28.07. | Toniebox Lite unveiled; launch already in August: tonies launches Toniebox Lite bundled at $ 79.99 (vs. ... | 448 | tonies announced the launch of Toniebox Lite, a smaller and lighter version of its flagship TB2, delivering the core listening experience while being compatible with all Tonies ever released. At $ 79.99... ► Artikel lesen | ||
| 27.07. | Strong Q2 order momentum creates strong visibility; chg.: ATOSS Q2 beat on sales and EBIT; Cloud backlog ... | 428 | Friday's Q2/H1 figures once again underlined the strength of ATOSS' recurring revenue engine, while management also provided confidence into FY27e backed by buoyant Q2 order intake. In detail: Q2 sales... ► Artikel lesen | ||
| 23.07. | Eckert & Ziegler: Strong Ga-68 outlook attracts competition; chg. est. & PT: While Curium's Ga-68 market entry and softer ... | 726 | The prostate theranostics market is expanding fast. Novartis reported Pluvicto Q2 2026 sales up c. 43% yoy. Stronger therapy volumes relate to more Ga-68 PSMA PET diagnostics, often utilizing EUZ's... ► Artikel lesen | ||
| 23.07. | Hoenle AG: FY25/26 guidance cut related to demand softness in Curing: hoenle cuts FY 25/26 guidance on persistent ... | 469 | Yesterday, hoenle announced a guidance cut for the current FY 25/26 on account of weaker-than-anticipated demand in Curing. In detail: Anticipating flat-ish FY 25/26 revenue development, management... ► Artikel lesen | ||
| 23.07. | Emerald Horizon AG: CEO reinforces commitment to accelerate commercial rollout: CEO Wagner pledges 75k shares as collateral ... | 428 | Emerald Horizon has announced that CEO and principal shareholder Florian Wagner has pledged 75,000 existing shares as collateral for a private Lombard loan. Importantly, the transaction does not involve... ► Artikel lesen | ||
| 23.07. | Q2 preview: Growth to further accelerate: tonies set for strong Q2 (eNuW: sales +37% yoy, € 109m) driven ... | 583 | tonies looks set to report a strong Q2 marked by further accelerating growth, carried by particularly high demand for the Toniebox 2, paving the way for strong margin expansion in H2. Q2 results are... ► Artikel lesen | ||
| 23.07. | Aiforia H1 profit warning triggers downgrade to HOLD: Profit warning: H1 2026 revenue fell 46% yoy to ... | 387 | Aiforia issued a profit warning with H1'26 revenues coming in at a mere € 0.75m, down from € 1.4m in H1'25 (-46% yoy), against our expectation of roughly doubling yoy, following last year's strong Clinical... ► Artikel lesen | ||
| 22.07. | THE NAGA GROUP AG: Earnings Call für Investoren am 05.08.2026: NuWays veranstaltet am 05.08.2026 um ... | 584 | Die NuWays AG veranstaltet einen Earnings Call mit THE NAGA GROUP AG. Unternehmen: THE NAGA GROUP AGDatum: 05.08.2026 15:00 Uhr Speaker: Octavian Patra?cu, Nach einer Präsentation besteht die Möglichkeit... ► Artikel lesen | ||
| 22.07. | Preliminary H1'26 revenue beats expectations; chg. est. & PT: NanoRepro's preliminary H1 26 sales ... | 522 | Yesterday, NanoRepro AG published its consolidated preliminary H1'26 revenue while also highlighting a key milestone from its systematic full internal review process. In detail: Double-digit growth... ► Artikel lesen | ||
| 22.07. | Record Q2 revenue as hotel platform scales: MHP Hotel posts record Q2 sales of €56.8m (+26% yoy), slightly ... | 605 | Yesterday, MHP released Q2 '26 hotel performance figures, posting the highest quarterly revenue in the company's history. In detail: Q2 hotel sales increased 26% yoy to € 56.8m (eNuW: € 57.8m), driven... ► Artikel lesen | ||
| 20.07. | On a winning streak; chg. est. & PT: ZEAL's strong jackpot-driven momentum, attractively priced UK ... | 562 | A favourable jackpot environment should drive a strong Q2 and, on early Q3 data, looks set to continue; the newly announced SevenCanyon acquisition adds a cheap, well-understood growth leg in the UK... ► Artikel lesen | ||
| 20.07. | NAV guidance adjusted on peer multiples; case fully intact: DBAG cuts FY26 NAV guidance to € 32-36 on ... | 490 | Topic: DBAG adjusted its FY26 NAV guidance to reflect lower valuation multiples of listed peers, while raising the EBITA outlook for Fund Investment Services. In detail:FY26 NAV per share is now seen... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.